[Federal Register Volume 88, Number 75 (Wednesday, April 19, 2023)]
[Notices]
[Page 24190]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-08250]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Agency for Healthcare Research and Quality


Notice of Meeting

AGENCY: Agency for Healthcare Research and Quality (AHRQ), Department 
of Health and Human Services (HHS).

ACTION: Notice of AHRQ subcommittee meeting.

-----------------------------------------------------------------------

SUMMARY: The subcommittee listed below is a part of AHRQ's Health 
Services Research Initial Review Group (IRG) Committee. Grant 
applications are to be reviewed and discussed at this meeting. The 
subcommittee meeting will be closed to the public.

DATES: See below for date of meeting:

1. Healthcare Safety and Quality Improvement Research (HSQR)
Date: June 14-15, 2023


ADDRESSES: Agency for Healthcare Research and Quality (Virtual Review), 
5600 Fishers Lane, Rockville, Maryland 20857.

FOR FURTHER INFORMATION CONTACT: (To obtain a roster of members, agenda 
or minutes of the non-confidential portions of the meeting.) Jenny 
Griffith, Committee Management Officer, Office of Extramural Research 
Education and Priority Populations, Agency for Healthcare Research and 
Quality (AHRQ), 5600 Fishers Lane, Rockville, Maryland 20857, Telephone 
(301) 427-1557.

SUPPLEMENTARY INFORMATION: In accordance with section 10 (a)(2) of the 
Federal Advisory Committee Act (5 U.S.C. app. 2), AHRQ announces 
meetings of the above-listed scientific peer review group, which is a 
subcommittee of AHRQ's Health Services Research Initial Review Group 
Committee. The subcommittee meeting will be closed to the public in 
accordance with the provisions set forth in 5 U.S.C. App. 2 section 
10(d), 5 U.S.C. 552b(c)(4), and 5 U.S.C. 552b(c)(6). The grant 
applications and the discussions could disclose confidential trade 
secrets or commercial property such as patentable material, and 
personal information concerning individuals associated with the grant 
applications, the disclosure of which would constitute a clearly 
unwarranted invasion of personal privacy. Agenda items for this meeting 
are subject to change as priorities dictate.

    Dated: April 13, 2023.
Marquita Cullom,
Associate Director.
[FR Doc. 2023-08250 Filed 4-18-23; 8:45 am]
BILLING CODE 4160-90-P